Optimization of the detection of inhibitory autoantibodies against the VWF-cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay.
Marc G JacqueminIsa Van HorenbeeckMirjam DebasseJelle ToelenJoke SchoetersIngrid VanlinthoutKathelijne PeerlinckDaan DierickxChristine Van LaerPublished in: International journal of laboratory hematology (2020)
Incubation of plasma samples with normal plasma at 25°C, 37°C, or 37°C after addition of Ca2+ can be used in a Bethesda assay for quantifying the inhibitory activity of antibodies interfering with ADAMTS13 in the chemiluminescent HemosILR AcuStar ADAMTS13 Activity assay.